SCHEMBL22179262

SCHEMBL22179262

CC(C)(C)OC(=O)N/C=C(\C=N)c1ccc(N)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 1/20 0.37
▸ EPHX2 P34913 1/20 0.36
▸ MAPK10 P53779 1/20 0.36
▸ PTGS1 P23219 2/20 0.35
▸ ELANE P08246 1/20 0.35
▸ ESRRG P62508 1/20 0.35
▸ PARP10 Q53GL7 1/20 0.34
▸ RAB9A P51151 2/20 0.34
▸ ADRB2 P07550 2/20 0.34
▸ ADRB1 P08588 2/20 0.34
▸ ADRB3 P13945 2/20 0.34
▸ CYP17A1 P05093 1/20 0.34
▸ PPARG P37231 1/20 0.34
▸ PPARA Q07869 1/20 0.34
▸ MIF P14174 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ MAOA P21397 1/20 0.33
▸ PRMT1 Q99873 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23912318 0.85 ALDH1A1 (0.43) MAPTEPHX2MAPK10ELANEPARP10
SCHEMBL24213545 0.82 HDAC1 (0.42) MAPTMAPK10ELANERAB9ACYP17A1
SCHEMBL24213565 0.73 ROCK1 (0.39) CYP17A1CYP1A2CYP3A4PRMT1
SCHEMBL7878972 0.72 EPHX2 (0.41) EPHX2MAPK10ESRRGRAB9ACYP17A1
SCHEMBL24290033 0.72 MAPK1 (0.40) MAPTMAPK10RAB9ALMNANPC1
SCHEMBL14896662 0.72 MASP2 (0.39) MAPTPARP10RAB9ALMNACYP1A2
SCHEMBL7438712 0.72 ADRB2 (0.40) MAPTEPHX2ELANEADRB2ADRB1
SCHEMBL14896712 0.71 ADRB2 (0.36) MAPTEPHX2ESRRGPARP10RAB9A
SCHEMBL15588634 0.71 MEN1 (0.46) MAPTEPHX2PTGS1ESRRGRAB9A
SCHEMBL24290006 0.71 P2RX7 (0.40) MAPK10RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023134688-A1 SALT OF ROCK INHIBITOR, CRYSTAL FORM OF SALT, COMPOSITION, AND PHARMACEUTICAL USE 武汉朗来科技发展有限公司 2023-07-20 — — WO disclosed
WO-2022012409-A1 ROCK INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF 武汉朗来科技发展有限公司 2022-01-20 — — WO disclosed
WO-2020140052-A1 CYCLIN-DEPENDENT KINASE INHIBITORS SPV THERAPEUTICS INC. (US) 2020-07-02 — — WO disclosed
Send feedback